Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa

NCT06368375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2024-04-16

No results posted yet for this study

Summary

Retrospective chart review study to elucidate the genotype and phenotype of patients with PRPF31-associated retinitis pigmentosa and asymptomatic carriers of the respective variant(s)

Conditions

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Laura Kuehlewein, MD · Department for Ophthalmology, University of Tuebingen

  • Susanne Kohl, PhD · Molecular Genetics Laboratory, Department for Ophthalmology, University of Tuebingen

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06368375 on ClinicalTrials.gov